APRI 21
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 33802977A | - Recalling Firm
- Apotex Inc.
- 4100 Weston Road
- Toronto
- M9L 2Y6
- Ontario
- CANADA
- Marketing Authorization Holder
- Barr Laboratoires Inc.
- 223 Quaker Road
- Pomona
- 10970-0519
- New York
- UNITED STATES
| A. APRI 21 | Film Coated Tablet | DIN 02317192 | 150 mcg / 30 mcg |
Recalled Products
-
APRI 21
Impurity identified as N-Butylbenzenesulfonamide (NBBS) detected during stability testing of the product.
Wholesalers/Distributors and Retail/Pharmacy in all provinces and Nunavut